Related by context. All words. (Click for frequent words.) 64 colon breast 64 breast colon 62 lung colorectal 62 prostate breast 60 ovarian breast 60 lung prostate 60 breast colorectal 59 colorectal 59 cancers 57 ovarian lung 57 colon prostate 57 lung colon 57 colorectal cancers 56 cervical breast 56 colorectal prostate 56 breast ovarian 56 bladder cancers 56 breast uterine 56 prostate colon 56 colorectal breast 56 breast cervical 56 colorectal lung 55 colorectal cancer 55 pancreatic lung 55 breast endometrial 55 prostate cancers 55 gastrointestinal cancers 55 rectal cancers 55 ovarian cancers 54 colon pancreas 54 Squamous cell 54 prostate colorectal 54 endometrial cancers 54 ovarian pancreatic 54 prostate pancreatic 53 bladder ovarian 53 faulty BRCA genes 53 colon cancers 53 Colon polyps 52 uterine ovarian 52 squamous cell skin 52 prostate lung 52 colorectal pancreatic 52 hormone refractory prostate 52 metastatic colorectal 52 CYT# potent vascular disrupting 52 lung pancreatic 52 pancreatic cancers 52 ovarian cervical 52 ovarian endometrial 52 breast ovary 51 testicular cancers 51 gastric cancers 51 colon pancreatic 51 breast pancreatic 51 leukemia myeloma 51 HER2 positive breast 51 squamous cell carcinomas 51 malignancies 51 uterine cancers 51 pancreatic prostate 51 lobular breast cancer 51 Basal cell 50 gynecologic cancers 50 cervical uterine 50 breast cancers 50 gynecological cancers 50 cirrhosis liver failure 50 colorectal gastric 50 rectal cancer 50 pancreatic colorectal 50 Renal cell carcinoma 50 nonmelanoma skin cancers 50 colorectal ovarian 50 cancer 50 deCODE BreastCancer 50 lung cancers 50 pancreatic ovarian 50 ovarian colon 49 pancreatic colon 49 pancreatic bladder 49 esophagus colon 49 metastatic HER2 positive 49 prostate ovarian 49 colon lung 49 squamous cell 49 metastatic colon cancer 49 pancreatic adenocarcinoma 49 leukaemias 49 Lung cancer 49 cisplatin resistant 49 Basal Cell 49 colorectal cancer CRC 49 melanoma basal cell 48 skeletal metastases 48 squamous cell cancers 48 basal cell cancer 48 adenocarcinomas 48 hormone therapy estrogen 48 hematological disorders 48 endometrial kidney 48 gynecologic malignancy 48 carcinomas 48 commonly mutated genes 48 gynecologic cancer 48 neuroendocrine tumors 48 Colorectal cancer CRC 48 Basal cell carcinoma 48 Basal cell carcinomas 48 endometrial ovarian 48 malignant tumors 48 HER2 positive cancers 48 adenocarcinoma 48 radiosensitive 47 metastatic cancers 47 Uterine cancer 47 Squamous 47 endometrial tumors 47 colorectum 47 invasive lobular 47 osteosarcomas 47 leukemias lymphomas 47 chronically immunosuppressed solid 47 colon cancer 47 Esophageal cancer 47 radiofrequency ablation RFA 47 ErbB2 positive 47 pancreatic gastric 47 hormonally sensitive 47 chemopreventive agents 47 bladder cervix 47 medullary thyroid cancer 47 serous ovarian cancer 47 commercialize deforolimus 47 gemcitabine chemotherapy 47 melanoma 47 malignant brain 47 Colorectal cancer 47 ovarian cancer 47 Colorectal 46 kidney urologic 46 squamous cell cancer 46 esophagus pancreas 46 gynecologic malignancies 46 lobular carcinomas 46 grade serous ovarian 46 ovarian colorectal 46 colon esophageal 46 metastatic melanoma 46 lung cancer NSCLC 46 anal cancers 46 bowel cancers 46 gynecological malignancies 46 gastric cancer 46 hormone receptor negative 46 Prostate cancer 46 esophageal cancers 46 neuroendocrine cancers 46 Squamous cell carcinomas 46 HER2 positive 46 nonsmall cell lung cancer 46 carcinoma 46 Malignant tumors 46 oesophageal adenocarcinoma 46 uterine cancer 46 curable cancers 46 lung cancer 46 endometrial cancer 46 oncoplastic 46 unresectable tumors 46 prostate cancer 46 Human papilloma virus 46 oligodendrogliomas 46 Thyroid nodules 46 prostate carcinomas 46 hormonal therapies 46 NSCLC 46 hematological diseases 46 medically inoperable 46 cancerdefine 46 commonest cancers 46 cervical ovarian 46 penile cancers 46 breast cancer 46 gynecological cancer 46 Renal Cell Carcinoma RCC 46 ductal cancer 46 atypical hyperplasia 45 nonmelanoma skin cancer 45 prostate bladder 45 Glioblastoma multiforme GBM 45 pleural mesothelioma 45 malignant melanoma 45 Metastatic 45 overexpress HER2 45 cetuximab Erbitux 45 Alessandro Riva 45 skin cancers 45 squamous cell carcinoma SCC 45 atypical ductal hyperplasia 45 noncancer 45 cervical cancers 45 Gastric cancer 45 BRCA deficient 45 Hepatocellular carcinoma 45 Menopausal hormone therapy 45 SIR Spheres microspheres 45 metastatic colorectal cancer 45 recurrent myocardial infarction 45 Cholangiocarcinoma 45 hormone deprivation 45 liver metastasis 45 advanced hepatocellular carcinoma 45 circulatory diseases 45 lung cancer asbestosis 45 biliary cancer 45 glioma rarer 45 malignant gliomas 45 tumors 45 ductal breast cancer 45 tumor metastases 45 recurrent metastatic 45 cirrhosis liver cancer 45 Leukemias 45 metastatic gastric 45 Squamous cell cancer 45 Uterine fibroids 45 liver cancer 45 androgen independent 45 Colorectal cancer screening 45 HER2 positive breast cancer 45 papillary renal cell carcinoma 45 neoadjuvant therapy 45 lung tumors 45 basal cell cancers 45 invasive breast cancer 45 hematologic malignancies 45 esophageal tumors 45 molecular abnormalities 44 de ath 44 Shark cartilage 44 Cancers 44 colon tumors 44 basal cell 44 fallopian tube carcinoma 44 cancer metastasizes 44 lobular cancer 44 Endometrial cancer 44 nasopharyngeal cancer 44 endometrial hyperplasia 44 HPV vaccine protects 44 ovarian uterine 44 squamous cell carcinoma 44 anaplastic 44 benign noncancerous 44 hepatocellular carcinoma HCC 44 renal cell carcinoma 44 vulvar cancers 44 bladder cancer 44 premalignant 44 fibrocystic disease 44 cell lung cancer 44 cervical cancer 44 Inflammatory breast cancer 44 multiple myeloma 44 HER2 amplified 44 Glioblastomas 44 epithelial tumors 44 colon rectal 44 precancer 44 BRCA1 mutation carriers 44 epithelial cancers 44 adenomatous polyps 44 GISTs 44 detect precancerous lesions 44 lung adenocarcinomas 44 brain tumors 44 pancreatic islet cell 44 pelvic malignancies 44 benign growths 44 solid tumors 44 oropharyngeal cancer 44 underwent prostatectomy 44 precursor lesions 44 commercializes oncology 44 Melanomas 44 macrovascular events 44 metastatic HER2 negative 44 basal cell carcinoma BCC 44 microsphere therapy 44 Acoustic neuromas 44 ductal lobular 44 Rectal cancer 44 Brain metastases 44 advanced adenomas 44 adjuvant radiation 44 colorectal cancer incidence 44 deCODE ProstateCancer TM 44 squamous cell lung cancer 44 Sezary syndrome 44 chemo resistant 44 carcinoid cancer 43 lymphomas leukemias 43 malignancy 43 lobular involution 43 Oesophageal cancer 43 Zyclara Cream 43 Pancreatic neuroendocrine tumors 43 precancerous cervical 43 gastric cardia 43 Gliomas 43 BRCA mutations 43 cancer mCRC 43 recurrent NSCLC 43 metastatic prostate 43 hereditary predisposition 43 metastatic kidney 43 grade gliomas 43 imatinib Gleevec 43 ccRCC 43 leiomyomas 43 metastatic pancreatic 43 diffuse gastric 43 Malignant gliomas 43 nonmelanoma 43 hormonally responsive 43 Aortic aneurysms 43 carcinoid tumors 43 Colorectal cancers 43 penile anal 43 metastatic castrate resistant 43 metastatic basal cell 43 metastatic disease 43 lignan intake 43 nonalcoholic steatohepatitis 43 malignant pleural mesothelioma 43 Cardiovascular disease 43 invasive cervical cancer 43 underarm lymph nodes 43 nonhormonal 43 carcinoid 43 colo rectal cancer 43 papillomaviruses 43 prostate cancer CaP 43 standard chemotherapy regimens 43 Chronic myeloid leukemia CML 43 Tay Sachs thalassemia 43 soft tissue sarcomas 43 mesotheliomas 43 Hepatocellular carcinoma HCC 43 peritoneal carcinomatosis 43 basal cell skin 43 lobular carcinoma 43 cardiovascular diseases 43 diseases fat malabsorption 43 Antibiotic resistant infections 43 radiation therapy SBRT 43 Epithelial ovarian cancer 43 renal cell carcinomas 43 ductal carcinomas 43 undergone radical prostatectomy 43 Breast cancer 43 Medullary thyroid cancer 43 ALCL 43 Vandetanib 43 peritoneal cancer 43 advanced HER2 positive 43 frequently benign tumor 43 HER2 positive tumors 43 systemic scleroderma 43 faulty BRCA2 gene 43 Stomach cancer 43 stage IIIB IV 43 hematological cancers 43 Acute lymphoblastic leukemia 43 hormone gastrin 43 Glioblastoma Multiforme GBM 43 prostate tumors 43 colorectal tumors 43 adenomatous polyp 43 invasive ductal 43 HNSCC 43 metastatic androgen independent 43 Digital Mammographic Imaging 43 Polyps 43 basal cell carcinomas 43 testicular germ cell 43 pre cancerous growths 42 oral squamous cell 42 Bladder cancer 42 ovary uterus 42 Fibroid tumors 42 ZACTIMA TM ZD# 42 lymphoid tumors 42 benign prostatic hyperplasia enlarged 42 sorafenib Nexavar ® 42 hepatocellular cancer 42 Prostate Cancer Prostate 42 methylation markers 42 Bloodstream infections 42 Teverelix 42 metastatic breast cancer 42 recurrent colorectal cancer 42 myocardial infarction MI 42 salpingo oophorectomy 42 recurrent glioblastoma multiforme GBM 42 male hormones androgens 42 pancreatic tumors 42 irinotecan chemotherapy 42 Helicobacter pylori infection 42 deCODE BreastCancer TM 42 cervical dysplasia 42 epithelial ovarian 42 metastatic cancer 42 gastric adenocarcinoma 42 pharyngeal cancer 42 basal cell carcinoma 42 colon rectal cancer 42 Human papillomavirus HPV 42 noncancerous tumors 42 Glioblastoma 42 leukemia lymphoma 42 relapsed SCLC 42 metastatic castration resistant 42 brain metastases 42 lymph node removal 42 Esophageal Cancer 42 endometriosis ovarian cysts 42 chemopreventive agent 42 sarcomas 42 noncardiovascular 42 cutaneous melanoma 42 seminoma 42 nonalcoholic steatohepatitis NASH 42 colorectal cancer screening 42 bone metastasis 42 Ischemic strokes 42 prostate carcinoma 42 lymphomas 42 Myelodysplastic syndromes MDS 42 Bowel cancer 42 anticancer therapy 42 squamous 42 invasive carcinoma 42 Androgen deprivation therapy 42 cholangiocarcinoma 42 nodal metastasis 42 Testicular cancer 42 cisplatin chemotherapy 42 Radical prostatectomy 42 prostate adenocarcinoma 42 nonmetastatic 42 computed tomography CT scans 42 lung adenocarcinoma 42 metastatic GIST 42 advanced epithelial ovarian 42 chemotherapy cisplatin 42 distant metastasis 42 lymph node enlargement 42 abnormal Pap smears 42 situ DCIS 42 pediatric acute lymphoblastic 42 Papillary 42 Malignant melanoma 42 Invasive Breast Cancer 42 BRCA2 mutations 42 recurrent ovarian 42 metastatic 42 neoplasias 42 Follicular lymphoma 42 pancreatic NET 42 papillary 42 progesterone receptor negative 42 urothelial carcinoma 42 ovarian carcinoma 42 mutated KRAS gene 42 pituitary adenomas 42 clinically localized prostate 42 lymphatic cancers 42 cancerous enlargement 42 histological subtypes 42 Peritoneal mesothelioma 42 familial pancreatic cancer 42 mammography screening 42 metastatic bladder 42 Metastases 42 malignant neoplasm 42 Malignant Melanoma 42 myelofibrosis polycythemia vera 42 ductal adenocarcinoma 42 urothelial cancer 42 thyroid cancers 42 oropharyngeal cancers 42 refractory colorectal cancer 42 lung cancer mesothelioma 42 cardiovascular disease hypertension 42 esophageal cancer 42 Colorectal Cancer 42 uveal melanoma 42 malignant neoplasms 42 acute lymphoid leukemia 42 Pap smear screening 42 simplex virus 42 malignant growths 42 GIST 42 allogeneic HSCT 42 Idiopathic pulmonary fibrosis 42 myelomas 42 cervical cancer genital warts 42 colonoscopy flexible sigmoidoscopy 42 TTR amyloidosis 41 Colorectal cancer incidence 41 Relapsing remitting MS 41 HER2 positive metastatic breast 41 precancerous colon polyps 41 Acute myeloid leukemia 41 melanoma skin 41 Metastatic colorectal cancer 41 contralateral breast 41 PROLARIS 41 carotid plaques 41 unresectable liver cancer 41 aerodigestive tract 41 prostate cancer CRPC 41 mTOR inhibitors 41 vulvar cancer 41 distant metastases 41 benign proliferative breast 41 idiopathic pulmonary fibrosis IPF 41 awaiting organ transplants 41 postmenopausal hormone replacement 41 gefitinib Iressa 41 hematologic disorders 41 hepatocellular carcinoma 41 meningiomas 41 repeat revascularization 41 secretory diarrhea 41 gastroenteritis conjunctivitis 41 Merkel cell carcinoma 41 Acute leukemia 41 Breast MRIs 41 mucinous 41 nasopharyngeal carcinoma 41 cardiovascular disease 41 invasive ductal carcinomas 41 pre cancerous lesions 41 Erbitux cetuximab 41 Kattlove 41 abnormal mammograms 41 BRCA1 mutations 41 fecal occult blood 41 cryptococcosis 41 invasive lobular carcinoma 41 monoclonal antibody therapies 41 Carcinoid tumors 41 recurrent ovarian cancer 41 stem cells CSCs 41 preoperative chemotherapy 41 adjuvant therapies 41 Ischaemic heart 41 metastatic lesions 41 dysplastic lesions caused 41 intestinal polyps 41 oesophageal cancers 41 benign breast 41 prophylactic mastectomies 41 HER2 overexpression 41 Cell Lung Cancer 41 myeloproliferative neoplasms 41 Uterine Cancer 41 HBeAg negative 41 tanned indoors 41 colorectal adenomas 41 Chronic diseases 41 Adenocarcinoma 41 Stomach stapling 41 estrogen progestin therapy 41 dasatinib Sprycel 41 metastatic renal cell carcinoma 41 solar keratosis 41 hormone receptor positive 41 renal carcinoma 41 liver scarring 41 alkylating agents 41 Prostate Lung Colorectal 41 gastrointestinal malignancies 41 metastatic lung cancer 41 prostate abnormalities 41 Liver transplants 41 PKCi 41 Breast Oncology 41 precancerous tumors 41 Hemorrhagic strokes 41 Folic acid supplements 41 chronic periodontitis 41 oophorectomy 41 Zinc deficiency 41 Recurrences 41 chemopreventive 41 asbestosis mesothelioma 41 immunological diseases 41 patients undergoing chemotherapy 41 bile duct cancers 41 oropharyngeal squamous cell carcinoma 41 unresectable 41 lobular 41 Cirrhosis 41 histologies 41 colorectal polyp 41 DVT PE 41 colorectal polyps 41 metastatic ovarian cancer 41 antiestrogen 41 advanced metastatic prostate 41 bilateral oophorectomy 41 Meningiomas 41 postmenopausal hormone 41 breast tumors 41 colorectal carcinoma 41 biliary tract cancers 41 HER2 negative 40 Seewaldt 40 lymphoproliferative disorders 40 pancreatic 40 Epidemiologic studies 40 ASCUS 40 VTEs 40 proliferative disorders 40 Chronic lymphocytic leukemia 40 prostate specific 40 neoplasia 40 BSGI MBI 40 Screening Trial 40 pediatric malignancies 40 gene BRCA2 40 sorafenib 40 liver metastases 40 Candida infection 40 Adjuvant chemotherapy 40 Pancreatic NET 40 bone metastases 40 cytoreduction 40 essential thrombocythemia 40 castrate resistant prostate cancer 40 olaparib 40 Hysterectomies 40 colorectal carcinomas 40 bevacizumab Avastin 40 PARP inhibition 40 intravenous bisphosphonates 40 abnormal pap smears 40 mutated BRAF gene 40 acoustic neuromas 40 abnormal cervical 40 breast carcinoma 40 Thyroid cancer 40 estrogen receptor negative 40 relapsed ovarian cancer 40 Bladder Cancer 40 metachronous 40 histological subtype 40 abnormal Pap tests 40 cervical cancer screenings 40 adjuvant radiotherapy 40 colorectal adenoma 40 cervical precancers 40 fecal immunochemical test 40 GnRH agonists 40 Squamous Cell 40 SPINK1 40 Screening mammograms 40 superficial bladder cancer 40 Glioblastoma multiforme 40 malignant lymphomas 40 glioblastoma multiforme GBM 40 beta carotene supplementation 40 Hepatocellular Carcinoma HCC 40 EGFR mutation 40 cause mesothelioma asbestosis 40 recurrent glioblastoma 40 esophageal adenocarcinoma 40 prostate tumor 40 endometrial carcinoma 40 urinary bladder cancer 40 vulvar intraepithelial neoplasia 40 PCNSL 40 resistant hormone refractory 40 breast caner 40 Zolinza 40 cervix uteri 40 LungAlert TM 40 cerebral vascular disease 40 acute leukemias 40 gliomas 40 Merck KGaA Erbitux 40 obese postmenopausal 40 radiation therapy 40 malignant ovarian 40 hematological malignancies 40 bladder tumors 40 ductal 40 Coronary heart 40 advanced adenoma 40 stereotactic radiotherapy 40 hereditary breast 40 endometrial 40 pneumococcal strains 40 tyrosine kinase inhibitors 40 colonoscopy screenings 40 promoter hypermethylation 40 cardio vascular disease 40 BCCs 40 chronic lymphocytic leukemia CLL 40 specific antigen 40 Accelerated Partial Breast Irradiation 40 lymphoma CTCL 40 mammography 40 prostate cancer mCRPC 40 Ovarian cysts 40 uterine tumors 40 hereditary breast cancer 40 atherothrombotic disease 40 Colon Cancer 40 KRAS status 40 elevated triglyceride levels 40 HCV infection 40 metastases 40 cell carcinoma 40 cervical carcinoma 40 hematologic cancers 40 Li Fraumeni 40 diseases 40 non squamous 40 pulmonary metastases 40 EGFR inhibitors 40 hormone refractory prostate cancer 40 cervical cancer screening 40 gastrointestinal stromal tumors 40 KRAS mutation 40 neoadjuvant treatment 40 colon cancer screening 40 colonoscopy sigmoidoscopy 40 cutaneous malignancies 40 leukemia aplastic anemia 40 Chronic Lymphocytic Leukemia CLL 40 chronic acid reflux 40 candidemia 40 metastatic malignant melanoma 40 renal tumors 40 Bacterial infection 40 distal colon cancer 40 Glioma 40 Hormone pills 40 resistant ovarian cancer 40 Surgical resection 40 breast carcinomas 40 differentiated thyroid 40 sarcomatoid 40 Non Hodgkins lymphoma 40 Avastin adjuvant 40 locoregional recurrence 40 lymphoma 40 PAP smears 40 localized prostate cancer 40 prostate specific antigen 40 SEER database 40 heavily pretreated 40 K ras mutations 40 Screening Trial DMIST 40 adjuvant therapy 40 Pulmonary Fibrosis 40 Benign breast 39 colorectal adenocarcinoma 39 presymptomatic 39 sarcosine 39 Lung Cancer 39 pre cancerous polyps 39 Cystic fibrosis affects 39 Acetaminophen overdose 39 breast cancer susceptibility genes 39 ovarian 39 Soft tissue sarcomas 39 mammograms Pap tests 39 metastatic prostate cancer 39 glioblastoma 39 HER2 ErbB2 39 palliative radiotherapy 39 pre cancerous 39 pancreatic cancer 39 Candida infections 39 Magnesium deficiency 39 cardiopulmonary diseases 39 angiogenesis inhibitors 39 Ectopic pregnancy 39 superficial basal cell carcinoma 39 Hip fractures 39 invasive ductal carcinoma 39 hemorrhagic strokes 39 prostate TURP 39 estrogen receptor positive 39 polyps growths 39 HCV infections 39 Folotyn 39 IOERT 39 taxane therapy 39 lung metastases 39 cancerous tumors 39 Breast Cancer Risk 39 postoperative pathology 39 astrocytomas 39 San Antonio Breast Cancer 39 fibroadenomas 39 seminomas 39 invasive ductal cancer 39 lymph node metastases 39 GBM tumors 39 non hodgkin lymphoma 39 Screening mammography 39 SCCHN 39 Metastatic melanoma 39 factor receptor EGFR 39 breast cancer subtypes 39 nonfasting triglyceride levels 39 genes BRCA1 39 opportunistic viral infection 39 Neurological disorders 39 gonococcal infection 39 precancerous 39 Chlamydia trachomatis infection 39 cell lymphomas 39 ocular melanoma 39 oral leukoplakia 39 often detect precancerous 39 Viral infections 39 osteoporotic fractures 39 untreated metastatic melanoma 39 Pleural mesothelioma 39 KRAS wild 39 CMV disease 39 European Randomized Study 39 benign moles 39 Anaplastic 39 5-FU/LV 39 situ LCIS 39 Genetic variants 39 serrated polyps 39 AML MDS 39 haematological cancers 39 Skin Cancers 39 antitumor effect 39 axitinib 39 oesophageal cancer 39 colorectal tumor 39 Vascular dementia 39 biliary tract cancer 39 minimally symptomatic 39 thoracoscopic lobectomy 39 mycosis fungoides 39 Periodontal disease 39 preventive mastectomies 39 KRAS mutations 39 nonproliferative 39 Thyroid Cancer 39 intracranial tumors 39 precancerous polyps 39 chemoprevention 39 gastrointestinal stromal tumors GISTs 39 fibroids endometriosis 39 cutaneous squamous cell carcinoma 39 diseases afflicting 39 dutasteride 39 Velcade bortezomib 39 basal cell nevus syndrome 39 cosmetic breast implants 39 Study Tanning beds 39 glioblastomas 39 Benign prostatic hyperplasia BPH 39 Ovarian cancer 39 neoplastic 39 Peripheral arterial disease 39 angiosarcoma 39 ependymomas 39 potentially cancerous growths 39 C. difficile infections 39 ruptured aneurysms 39 Cervical Cancer Early 39 gastrointestinal stromal tumors GIST 39 pancreatic carcinoma 39 recurrent prostate cancer 39 PET CT 39 K ras gene 39 Vulvar 39 colon cancer screenings 39 childhood sunburns 39 precancers 39 dysplastic nevi 39 inflammatory bowel diseases 39 thrombotic events 39 risk stratification 39 oesophageal squamous cell carcinoma 39 GIST tumors 39 metastatic brain tumor 39 gastric carcinoma 39 PSADT 39 Squamous Cell Carcinoma 39 postmenopausal breast cancer 39 metastatic adenocarcinoma 39 refractory multiple myeloma 39 malignant pheochromocytoma 39 micrometastases 39 Scorpion venom 39 gastrointestinal GI cancers 39 PTEN mutations 39 Inflammatory bowel diseases 39 acrylamide intake 39 indolent NHL 39 Radiation therapy 39 chemoradiotherapy 39 ASPS statistics 39 mammary cancers 39 relapsed leukemia 39 neuroblastomas 39 tumor histology 39 non Hodgkin lymphoma 39 anthracyclines 39 PSA screening 39 B CLL 39 medulloblastomas 39 breast cancer recurrences 39 Chronic lymphocytic leukemia CLL 39 Hypertensive heart 39 narcolepsy cataplexy 39 colorectal neoplasms 39 dimensional conformal radiotherapy 39 neoadjuvant chemotherapy 39 Salvatore Glorioso mayor 39 nodular melanoma 39 papillomas 39 NOMID 39 abnormal growths 39 CT Colonography 39 TORISEL 39 smoldering myeloma 39 PGDH 39 Chronic HCV infection 39 HER2 + 39 cervical cancer precursors 39 overtreated 39 Malignant glioma 39 Glioblastoma Multiforme 39 therapy IMRT 39 Kufs disease 39 symptomatic fibroids 39 bowel cancer 39 acne rosacea 39 cervical screenings 39 Prostrate cancer 39 mammography ultrasound 39 Chlamydia infection 39 colon polyps 39 diagnostic mammograms 39 mitochondrial disorders 39 familial adenomatous polyposis 38 melanoma lesions 38 laryngeal cancer 38 Enlarged prostate 38 mCRC 38 Bone metastases 38 chlamydial infection 38 Adenomas 38 thyroid tumors 38 Penile cancer 38 undergone mastectomies 38 Prostate Cancer 38 prostate 38 benign prostate 38 precancerous lesions 38 bronchus cancer 38 Autoimmune diseases 38 Flexi Scope 38 untreated celiac disease 38 Acne vulgaris 38 MRgFUS 38 Metastatic breast cancer 38 mammograms pap tests 38 Chlamydia infections 38 estrogen receptor progesterone receptor 38 skin sparing mastectomy 38 rheumatology clinics 38 ipsilateral breast 38 gynecologic oncologists 38 incurable illnesses 38 barium enemas 38 MRSA bloodstream infection 38 colorectal screening 38 untreated chlamydia 38 sPLA2 38 estrogen progestin combination 38 Tumours